Cargando…
Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols
BACKGROUND: Multidrug resistance (MDR) is a major obstacle in cancer treatment and is often the result of overexpression of the drug efflux protein, P-glycoprotein (P-gp), as a consequence of hyperactivation of NFκB, AP1 and Nrf2 transcription factors. In addition to effluxing chemotherapeutic drugs...
Autores principales: | Suttana, Wipob, Mankhetkorn, Samlee, Poompimon, Wilart, Palagani, Ajay, Zhokhov, Sergey, Gerlo, Sarah, Haegeman, Guy, Berghe, Wim Vanden |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873443/ https://www.ncbi.nlm.nih.gov/pubmed/20438634 http://dx.doi.org/10.1186/1476-4598-9-99 |
Ejemplares similares
-
Effect of CIK on multidrug-resistance reversal and increasing the sensitivity of ADR in K562/ADR cells
por: WANG, LEI, et al.
Publicado: (2014) -
Tackling Chronic Inflammation with Withanolide Phytochemicals—A Withaferin A Perspective
por: Logie, Emilie, et al.
Publicado: (2020) -
Inhibition of the NF-κB Signaling Pathway by a Novel Heterocyclic Curcumin Analogue
por: Katsori, Anna-Maria, et al.
Publicado: (2015) -
Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
por: Wang, Yu Jia, et al.
Publicado: (2017) -
Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A
por: vel Szic, Katarzyna Szarc, et al.
Publicado: (2017)